Brett R. Blackman
Corporate Officer/Principal at University of Virginia
Brett R. Blackman active positions
| Companies | Position | Start | End |
|---|---|---|---|
| University of Virginia | Corporate Officer/Principal | 2010-06-22 | - |
American Heart Association, Inc.
 American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Corporate Officer/Principal | 2010-06-22 | - |
| Robert M Berne Cardiovascular Research Center | Corporate Officer/Principal | 2010-06-22 | - |
Career history of Brett R. Blackman
Former positions of Brett R. Blackman
| Companies | Position | Start | End |
|---|---|---|---|
| OMEGA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2018-05-31 | 2019-05-31 |
Senda Biosciences, Inc.
 Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2016-08-31 | 2018-10-31 |
Cogen Immune Medicine, Inc.
 Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 2016-03-31 | 2018-10-31 |
| EVELO BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2016-03-31 | 2016-09-30 |
HemoShear Therapeutics, Inc.
 HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | Director/Board Member | 2007-12-31 | 2015-07-31 |
| Chief Tech/Sci/R&D Officer | 2010-06-22 | 2015-07-31 | |
| Founder | 2007-12-31 | 2015-07-31 |
Training of Brett R. Blackman
| University of Pennsylvania | Doctorate Degree |
| Drexel University | Undergraduate Degree |
Statistics
International
| United States | 11 |
Operational
| Chief Tech/Sci/R&D Officer | 5 |
| Corporate Officer/Principal | 3 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| EVELO BIOSCIENCES, INC. | Health Technology |
| OMEGA THERAPEUTICS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
HemoShear Therapeutics, Inc.
HemoShear Therapeutics, Inc. Medical/Nursing ServicesHealth Services HemoShear Therapeutics LLC engages in the development of human-relevant systems for applications in drug research and development. It creates human relevant systems that replicate the biology of organ systems and diseases throughout drug discovery and development. The firm's technology imposes human-derived hemodynamic forces on human primary cells to recreate human biology. The company was founded by Brian R. Wamhoff and Brett R. Blackman in 2008 and is headquartered in Charlottesville, VA. | Health Services |
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services American Heart Association, Inc. operates a voluntary health organization funded by private contributions. The organization offers services for coronary heart diseases and strokes, high blood cholesterol & physical inactivity, obesity, and diabetes. The company was founded in 1924 and is headquartered in Dallas, TX. | Commercial Services |
| Robert M Berne Cardiovascular Research Center | |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Cogen Immune Medicine, Inc. develops immune modulation therapeutics which control immune system. Its platform includes therapeutics, vaccines, clinical decision making, and immune health. The company was founded by Noubar B. Afeyan in 2017 and is headquartered in Cambridge, MA. | Health Technology |
Senda Biosciences, Inc.
Senda Biosciences, Inc. BiotechnologyHealth Technology Kintai Therapeutics, Inc. engages in discovering and development of precision enteric medicine. It offers discovery platform, enteric biology and analytics, and precision enteric medicines. The company was founded in 2016 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Brett R. Blackman
- Experience
